Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CEVA, Inc. - Common Stock (NQ: CEVA )

34.67 -0.29 (-0.83%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CEVA, Inc. - Common Stock

< Previous 1 2 3 Next >
CEVA: Q1 Earnings Insights
Via Benzinga
CEVA's Return On Capital Employed Insights
Via Benzinga
Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket
Gainers 
Via Benzinga
D.R. Horton To $84? Plus This Analyst Slashes PT On CEVA By 25%
  Raymond James boosted the price target on D.R. Horton, Inc. (NYSE: DHI) from $77 to $84. D.R. Horton shares rose 1.2% to $76.38 in pre-market trading. 
Via Benzinga
7 Small-Cap Stocks to Buy Before the Market Starts to Soar in 2023
Although small-cap stocks to buy may be risky because of their relatively unproven nature, these ideas command serious respect. 
Via InvestorPlace
CEVA Registers 9% Revenue Growth In Q2 Reflecting Strength In Wireless Space
Via Benzinga
Recap: CEVA Q2 Earnings
  CEVA (NASDAQ:CEVA) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
CEVA Clocks 35% Revenue Growth In Q1 Powered By Dominance In Wireless IP
Via Benzinga
Spare Parts Logistics Market | Impact of Covid-19 on Business Performance, Gross Margin and Forecast to 2031
The report provides an analysis of market drivers, constraints, strategies and trends that can influence the overall development. 
Via EIN Presswire
Exposures COVID-19
CEVA: Q1 Earnings Insights
CEVA (NASDAQ:CEVA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings CEVA beat estimated earnings by 5.88%,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 16, 2022
Upgrades According to Compass Point, the prior rating for Comerica Inc (NYSE:CMA) was changed from Neutral to Buy. Comerica earned $1.66 in the fourth quarter, compared to $1.49... 
Via Benzinga
CEVA Tops Q4 Consensus Backed By Robust Demand For IP, Chip Design Portfolio
Via Benzinga
Recap: CEVA Q4 Earnings
  CEVA (NASDAQ:CEVA) reported its Q4 earnings results on Tuesday, February 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For February 15, 2022
Companies Reporting Before The Bell • FirstService (NASDAQ:FSV) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.07 billion. 
Via Benzinga
CEVA's Earnings Outlook
CEVA (NASDAQ:CEVA) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that CEVA will report an... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... 
Via Benzinga
CEVA, inc (CEVA) Q3 2021 Earnings Call Transcript
CEVA earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
CEVA Beats Q3 Backed By Edge Tech, Intrinsix Chip Design
CEVA Inc (NASDAQ: CEVA) reported third-quarter FY21 revenue growth of 31% year-on-year to $32.8 million, beating the consensus of $31.2 million. Segments: ... 
Via Benzinga
Earnings Roundup: Berkshire Hathaway, The Trade Desk, CEVA
Berkshire Hathaway sticks to its main focus and is not lighting the world on fire, but it's still doing well. 
Via The Motley Fool
CEVA, inc (CEVA) Q2 2021 Earnings Call Transcript
CEVA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Information Technology Stocks Moving In Monday's Intraday Session
Gainers Aehr Test Systems (NASDAQ:AEHR) stock increased by 13.16% to $6.62 during Monday's regular session. Aehr Test Systems's stock is trading at a volume of 2.6... 
Via Benzinga
CEVA: Q2 Earnings Insights
Shares of CEVA (NASDAQ:CEVA) rose 2.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 83.33% year over year to $0.22... 
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Gainers Atomera (NASDAQ:ATOM) stock rose 14.56% to $19.58 during Wednesday's pre-market session. The market value of their outstanding shares is at $451.0 million. The... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2021
Upgrades B of A Securities upgraded the previous rating for UGI Corp (NYSE:UGI) from Neutral to Buy. UGI earned $1.99 in the second quarter, compared to $1.56 in the year-... 
Via Benzinga
Looking Into CEVA's Return On Capital Employed
CEVA (NASDAQ:CEVA) reported Q1 sales of $25.40 million. Earnings fell to a loss of $1.33 million, resulting in a 155.26% decrease from last quarter. CEVA earned $2.41 million, and... 
Via Benzinga
Looking Into CEVA's Return On Capital Employed
During Q1, CEVA (NASDAQ:CEVA) brought in sales totaling $25.40 million. However, earnings decreased 155.26%, resulting in a loss of $1.33 million. CEVA earned $2.41 million, and... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021
Upgrades For CEVA Inc (NASDAQ:CEVA), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year... 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3.... 
Via Benzinga
CEVA Inc (CEVA) Q1 2021 Earnings Call Transcript
CEVA earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
40 Stocks Moving In Monday's Mid-Day Session
Gainers Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares jumped 64.2% to $3.4962 on above-average news. Obalon Therapeutics, Inc. (NASDAQ: OBLN) gained 35% to $2.97. Cue... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.